Insights from Digital Pharma Leaders
Refine search
Biotechnology
USA-based biotech major Amgen is now defending a proposed class action over the cloud breach it disclosed in late July, the first sign that an incident described in a regulatory filing three weeks ago will carry a long legal tail. 19 August 2026
Pharmaceutical
USA-based bioanalysis firm Dash Bio has raised $30 million in a series A round led by Oak HC/FT, money it will spend on a laboratory that hands much of drug safety and efficacy testing to robots. Existing backers Freestyle Capital and Swift Ventures also took part. The round takes total funding at the Waltham, Massachusetts company to $47.5 million. 19 August 2026
Pharmaceutical
An Expert View from Ella Green, Maggie Gisseleire, and Laura Johnson, Carpmaels & Ransford. 7 August 2026
Pharmaceutical
German biotech services company Evotec has entered a research and development collaboration with Odyssey Therapeutics to discover new small molecule candidates for autoimmune and inflammatory diseases, the companies announced Thursday. 7 August 2026
Biotechnology
USA-based techbio Receptor.AI and Sethera Therapeutics have formed a research alliance combining computational modeling with peptide library screening to identify potential drugs for hard-to-drug targets. 3 August 2026
Biotechnology
USA-based biotech major Amgen has disclosed what it called a material cybersecurity incident, in which hackers exfiltrated company data, including proprietary information and patient protected health information, from cloud environments run by third-party providers. The company revealed the breach in a filing with the US Securities and Exchange Commission (SEC). 3 August 2026
Biotechnology
Relation Therapeutics has expanded its strategic collaboration with UK pharma major GSK, broadening work aimed at using artificial intelligence and human tissue data to identify new drug targets. 30 July 2026
Pharmaceutical
A young California start-up wants to do for drug development what enterprise software did for accounting and sales: put the whole thing in one connected system. Cheiron, based in Los Altos, has raised $8 million in seed funding to build what it calls an AI-native operating system for drug programs. 23 July 2026
Pharmaceutical
Chicago, USA-based artificial intelligence company Tempus AI yesterday announced that it has entered into a definitive agreement to acquire genomics partner Personalis.
. 21 July 2026
Pharmaceutical
US pharma major Bristol Myers Squibb is expanding its partnership with NVIDIA, with plans to deploy an NVIDIA DGX SuperPOD built on DGX Vera Rubin NVL72 systems to support AI-led drug discovery and development. 20 July 2026
Pharmaceutical
US AI drug discovery firm Chai Discovery has raised $400 million in a Series C financing, valuing the San Francisco-based company at $3.8 billion as it looks to expand use of its molecular design platform across the pharma industry. 15 July 2026
Biotechnology
AI-driven biotech Insilico Medicine and China Medical System Holdings have expanded their drug discovery alliance with a new central nervous system (CNS) program. 14 July 2026
Biotechnology
Chai Discovery has signed a collaboration with Novartis to use artificial intelligence in the discovery of therapeutic antibodies, adding another large pharmaceutical company to its growing customer base. The agreement covers multiple biological targets, although financial terms and the specific disease areas involved were not disclosed. 14 July 2026
Biosimilars
South Korean biosimilar specialist Samsung Bioepis today announced that it has entered into a license agreement with Proteina Co to collaborate on a government-supported national R&D initiative aimed at developing AI-based antibody therapeutics. 9 July 2026
Biotechnology
China’s MindRank AI has completed a $52 million Series B financing round, with investors including leading renminbi and US dollar funds. Kaiwu Capital served as the exclusive financial advisor. 9 July 2026
Pharmaceutical
In 2026, the STADA Health Report captures Europe’s healthcare landscape shaped by colliding forces: Healthcare systems under sustained pressure, a population empowered to take their health into their own hands, and the rapid arrival of AI in everyday personal care. 6 July 2026
Pharmaceutical
China’s Insilico Medicine , a leader in clinical-stage generative AI for drug discovery, has entered into a strategic collaboration agreement with Japanese pharma major Takeda to use its proprietary end-to-end platform, Pharma.AI, to advance drug candidates across the company's therapeutic areas. 2 July 2026
Biotechnology
Privately-held German pharma major Boehringer Ingelheim has entered a multi-project research collaboration with New York-based Immunai to identify T-cell targets in oncology and autoimmune disease. 25 June 2026
Pharmaceutical
Danish pharma major Novo Nordisk has reportedly been subject to ransom claims from two hacker groups, which separately sought multimillion-dollar ransom payments after gaining unauthorized access to a limited number of internal IT systems. 24 June 2026
Pharmaceutical
An Expert View from Rob Goodwin, Chief Operating Officer, Parexel. 24 June 2026
Biotechnology
USA-based biotech major Amgen is now defending a proposed class action over the cloud breach it disclosed in late July, the first sign that an incident described in a regulatory filing three weeks ago will carry a long legal tail. 19 August 2026
Pharmaceutical
USA-based bioanalysis firm Dash Bio has raised $30 million in a series A round led by Oak HC/FT, money it will spend on a laboratory that hands much of drug safety and efficacy testing to robots. Existing backers Freestyle Capital and Swift Ventures also took part. The round takes total funding at the Waltham, Massachusetts company to $47.5 million. 19 August 2026
Pharmaceutical
An Expert View from Ella Green, Maggie Gisseleire, and Laura Johnson, Carpmaels & Ransford. 7 August 2026
Pharmaceutical
German biotech services company Evotec has entered a research and development collaboration with Odyssey Therapeutics to discover new small molecule candidates for autoimmune and inflammatory diseases, the companies announced Thursday. 7 August 2026
Biotechnology
USA-based techbio Receptor.AI and Sethera Therapeutics have formed a research alliance combining computational modeling with peptide library screening to identify potential drugs for hard-to-drug targets. 3 August 2026
Biotechnology
USA-based biotech major Amgen has disclosed what it called a material cybersecurity incident, in which hackers exfiltrated company data, including proprietary information and patient protected health information, from cloud environments run by third-party providers. The company revealed the breach in a filing with the US Securities and Exchange Commission (SEC). 3 August 2026
Biotechnology
Relation Therapeutics has expanded its strategic collaboration with UK pharma major GSK, broadening work aimed at using artificial intelligence and human tissue data to identify new drug targets. 30 July 2026
Pharmaceutical
A young California start-up wants to do for drug development what enterprise software did for accounting and sales: put the whole thing in one connected system. Cheiron, based in Los Altos, has raised $8 million in seed funding to build what it calls an AI-native operating system for drug programs. 23 July 2026
Pharmaceutical
Chicago, USA-based artificial intelligence company Tempus AI yesterday announced that it has entered into a definitive agreement to acquire genomics partner Personalis.
. 21 July 2026
Pharmaceutical
US pharma major Bristol Myers Squibb is expanding its partnership with NVIDIA, with plans to deploy an NVIDIA DGX SuperPOD built on DGX Vera Rubin NVL72 systems to support AI-led drug discovery and development. 20 July 2026
Pharmaceutical
US AI drug discovery firm Chai Discovery has raised $400 million in a Series C financing, valuing the San Francisco-based company at $3.8 billion as it looks to expand use of its molecular design platform across the pharma industry. 15 July 2026
Biotechnology
AI-driven biotech Insilico Medicine and China Medical System Holdings have expanded their drug discovery alliance with a new central nervous system (CNS) program. 14 July 2026
Biotechnology
Chai Discovery has signed a collaboration with Novartis to use artificial intelligence in the discovery of therapeutic antibodies, adding another large pharmaceutical company to its growing customer base. The agreement covers multiple biological targets, although financial terms and the specific disease areas involved were not disclosed. 14 July 2026
Biosimilars
South Korean biosimilar specialist Samsung Bioepis today announced that it has entered into a license agreement with Proteina Co to collaborate on a government-supported national R&D initiative aimed at developing AI-based antibody therapeutics. 9 July 2026
Biotechnology
China’s MindRank AI has completed a $52 million Series B financing round, with investors including leading renminbi and US dollar funds. Kaiwu Capital served as the exclusive financial advisor. 9 July 2026
Pharmaceutical
In 2026, the STADA Health Report captures Europe’s healthcare landscape shaped by colliding forces: Healthcare systems under sustained pressure, a population empowered to take their health into their own hands, and the rapid arrival of AI in everyday personal care. 6 July 2026
Pharmaceutical
China’s Insilico Medicine , a leader in clinical-stage generative AI for drug discovery, has entered into a strategic collaboration agreement with Japanese pharma major Takeda to use its proprietary end-to-end platform, Pharma.AI, to advance drug candidates across the company's therapeutic areas. 2 July 2026
Biotechnology
Privately-held German pharma major Boehringer Ingelheim has entered a multi-project research collaboration with New York-based Immunai to identify T-cell targets in oncology and autoimmune disease. 25 June 2026
Pharmaceutical
Danish pharma major Novo Nordisk has reportedly been subject to ransom claims from two hacker groups, which separately sought multimillion-dollar ransom payments after gaining unauthorized access to a limited number of internal IT systems. 24 June 2026
Pharmaceutical
An Expert View from Rob Goodwin, Chief Operating Officer, Parexel. 24 June 2026
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze